A dynamic rRNA ribomethylome drives stemness in acute myeloid leukemia.
Fengbiao ZhouNesrine ArouaYi LiuChristian RohdeJingdong ChengAnna-Katharina WirthDaria FijalkowskaStefanie GöllnerMichelle LotzeHaiyang YunXiaobing YuCaroline PabstTim SauerThomas OellerichHubert ServeChristoph RölligMartin BornhäuserChristian ThiedeClaudia Dorothea BaldusMichaela FryeSimon RaffelJeroen KrijgsveldIrmela JeremiasRoland BeckmannFlavia Carla MeottiCarsten Muller-TidowPublished in: Cancer discovery (2022)
The development and regulation of malignant self-renewal remains an unresolved issue. Here, we provide biochemical, genetic, and functional evidence that dynamics in ribosomal RNA (rRNA) 2'-O-methylation regulate leukemia stem cell (LSC) activity in vivo. A comprehensive analysis of the rRNA 2'-O-methylation landscape of 94 acute myeloid leukemia (AML) patients revealed dynamic 2'-O-methylation specifically at exterior sites of ribosomes. rRNA 2'-O-methylation pattern is closely associated with AML development stage and LSC gene expression signature. Forced expression of 2'-O-methyltransferase FBL induced an AML stem cell phenotype and enabled engraftment of non-LSC leukemia cells in NSG mice. Enhanced 2'-O-methylation redirected the ribosome translation program towards amino acid transporter mRNAs enriched in optimal codons and subsequently increased intracellular amino acid levels. Methylation at the single site 18S-guanosine 1447 was instrumental for LSC activity. Collectively, our work demonstrates that dynamic 2'-O-Me at specific sites on ribosomal RNAs shifts translational preferences and controls AML-LSC self-renewal.
Keyphrases
- acute myeloid leukemia
- stem cells
- genome wide
- dna methylation
- gene expression
- allogeneic hematopoietic stem cell transplantation
- amino acid
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- epithelial mesenchymal transition
- skeletal muscle
- oxidative stress
- prognostic factors
- endothelial cells
- signaling pathway
- copy number
- drug induced
- acute lymphoblastic leukemia
- insulin resistance
- patient reported outcomes
- high glucose
- reactive oxygen species